Kristin Bigos, Ph.D.
Dr. Kristin Bigos is Senior Director of CNS at BullFrog AI. Dr. Bigos is responsible for BullFrog AI’s research and development involving CNS disorders. She is a highly accomplished professor of Medicine, Psychiatry, and Pharmacology at the Johns Hopkins University School of Medicine. Her NIH-funded academic research is focused on neuropsychiatric drug development and developing […]
Thomas Hazel, Ph.D.
Thomas Hazel is Vice President of Scientific Operations at BullFrog AI. He is responsible for building and scaling scientific teams, advancing platform-based drug discovery, and translating innovative science into clinical-stage programs. Previously, he was BullFrog’s Vice President of Drug Development for five years. Before joining the Company, Thomas was a Senior Vice President of Research […]
Eric Roos
Eric Roos is Senior Vice President of Business Development & Corporate Strategy at BullFrog AI. He is responsible for scaling BullFrog’s end-to-end AI workflow for drug development through high-value corporate strategy, enterprise business development, strategic partnerships, and more. A seasoned biotech executive with more than 30 years of experience, Eric previously held roles like Chief […]
John Stewart, MBA
John Stewart is Senior Vice President of Commercial Sales at BullFrog AI. He is responsible for sales and strategy of BullFrog’s end-to-end AI workflow for drug development. With more than 25 years of sales and strategy experience in global and national enterprise IT Services and solutions, John most recently served in executive IT sales and […]
JT Koffenberger
JT Koffenberger is Head of Information Technology at BullFrog AI. JT is responsible for digital security, information technology services, custom application development, and more. With more than 30 years of experience leveraging IT services for business, he was previously Founder of Delmarva Group, LLC. and Director of IT Architecture for Day and Zimmerman.
Josh Blacher, MBA
Josh Blacher is Chief Financial Officer of BullFrog AI and is responsible for financial and accounting operations, capital markets strategy, and corporate development. With more than two decades of financial leadership experience in the life sciences, Josh’s prior experience includes Chief Financial and Business Officer for InMed Pharmaceuticals, Therapix Biosciences, and Galmed Pharmaceuticals. Earlier in […]
Vin Singh, MBA
Vin Singh is Founder, Chairman, and CEO of BullFrog AI. Vin is responsible for the executive leadership of BullFrog AI and brought the Company public in 2023. Previously, he was the Founder & CEO at Next Healthcare Inc., co-founder of MaxCyte Inc. (Nasdaq: MXCT), and a global cell therapy executive, with experience in operations and […]